Overview

An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
To determine the safety profile of Androxal in men with secondary hypogonadism.
Phase:
Phase 3
Details
Lead Sponsor:
Repros Therapeutics Inc.
Treatments:
Citric Acid
Clomiphene
Enclomiphene
Zuclomiphene